Filter
660
Featured
49
189
Language
Document type
498
66
45
20
19
6
4
1
1
Countries
26
21
20
18
18
15
14
14
14
14
13
13
12
11
11
11
11
9
8
7
7
6
6
6
6
6
5
5
5
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
246
43
23
11
11
7
2
Toolboxes
264
88
16
13
12
12
10
8
7
7
6
6
6
5
5
5
3
3
2
1
Stories of putting people at the centre
Accessed: 20.11.2019
2020 is a critical year for our Joint Programme as we collectively define the path to getting back on track to ending the AIDS epidemic by 2030. Our revised timelines for adoption of the next strategy are highly ambitious. We need the full support of all the tremendously dedicated people in UNAIDS-w
...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
ILEP Technical Guide
UNAIDS/99.31E (English original, June 1999)
1st revision, April 2000
Compiled by Tin Geber for HIVOS. London, March 2018
Supplement October 2010
HIV/AIDS, security and conflict: making the connections
Regional Operational Plan 2016 FY17 Strategic Direction Summary
2 May 2016
Updated on 6 APRIL 2020
There are serious concerns that the situation might escalate in the next weeks modelling the epi curve of other regions. The interlinkages between human mobility and the current pandemic of COVID-19 are well established, and while international flights have been suspended i
...
Washington, D.C., ÉUA, du 26 au 30 septembre 2016
Point 4.10 de l’ordre du jour provisoire
CD55/14 8 juillet 2016
Original : anglais
Washington, D.C., EUA, del 26 al 30 de septiembre del 2016
Punto 4.10 del orden del día provisional
CD55/14 8 de julio del 2016
Original: inglés
Learning from earthquake relief and recovery operations
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
